Skip to main content

Peer Review reports

From: The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer

Original Submission
18 Mar 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 Aug 2023 Reviewed Reviewer Report
11 Aug 2023 Reviewed Reviewer Report
7 Sep 2023 Author responded Author comments - ZengNan Mo
Resubmission - Version 3
7 Sep 2023 Submitted Manuscript version 3
13 Sep 2023 Author responded Author comments - ZengNan Mo
Resubmission - Version 4
13 Sep 2023 Submitted Manuscript version 4
17 Sep 2023 Author responded Author comments - ZengNan Mo
Resubmission - Version 5
17 Sep 2023 Submitted Manuscript version 5
24 Sep 2023 Reviewed Reviewer Report
26 Sep 2023 Reviewed Reviewer Report
30 Sep 2023 Author responded Author comments - ZengNan Mo
Resubmission - Version 6
30 Sep 2023 Submitted Manuscript version 6
10 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
13 Oct 2023 Editorially accepted
23 Oct 2023 Article published 10.1186/s12885-023-11523-9

You can find further information about peer review here.

Back to article page